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Accessible Summary
• Asthma is a problem for many people.
• Some people need help with their medicines for asthma.
• People who help with medicines should know how medicines work and how they are used.
• This study found that many helpers need more education about asthma medicines.
Abstract
Background: People who have an intellectual or developmental disability (IDD) and 
asthma are at greater risk of poor health outcomes. They often require assistance 
from caregivers when managing their medicines. The objective of this pilot study was 
to assess the level of understanding of asthma self- management concepts of family 
caregivers who provide assistance to people who IDD and asthma. Results will in-
form future needs assessment and intervention studies.
Materials and Methods: Nineteen caregivers of people who have asthma and IDD completed 
a mailed survey. The survey included scales to measure asthma self- management concepts, 
inhaler technique knowledge, medication adherence and control of asthma. The caregivers 
were instructed to complete most of the scales with reference to the person with IDD.
Results: Most caregivers had acceptable health literacy, but had low scores on the 
asthma self- management and inhaler technique tests. The most frequently cited barri-
ers to controlling asthma were inadequate caregiver and patient education about the 
illness as well as knowing and avoiding asthma triggers. The most frequently cited bar-
riers to medication management were knowing inhaler technique, knowledge of medi-
cation and forgetting to use medication. Asthma was controlled in 63.2% of patients, 
while almost 75% of patients were considered nonadherent to controller therapy.
Conclusions: Most caregivers had inadequate understanding of asthma self- 
management as well as inhaler technique despite having high health literacy. 
Improving caregiver and patient knowledge and skills may lead to better asthma 
control.
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1  | INTRODUC TION
While asthma appears to be at least as prevalent in people with IDD 
as compared to the general population, about 8% of the population 
(Morin, Mérineau- Côté, Ouellette- Kuntz, Tassé, & Kerr, 2012), other 
studies have documented a higher prevalence of up to 12% (Davis, 
2016). People with IDD and asthma are at greater risk of emergency 
room use, hospitalisation and mortality than the general population 
(Gale, Naqvi, & Russ, 2009; Kerins, Petrovic, Bruder, & Gruman, 2008; 
Reichard, Stolzle, & Fox, 2011; Schieve et al., 2012). People with IDD 
face challenges related to self- management that often require the 
assistance of caregivers. In essence, self- management of chronic dis-
ease becomes supported self- management, whereby the caregiver is 
involved to the extent necessary to assist the care- recipient manage 
their asthma therapy. The person with IDD and the support network 
of caregivers must work together to control illness. Successful man-
agement of chronic illness requires an informed and competent team. 
Factors that should be taken into consideration for self- management 
to be successful would include considering the patient’s level of 
functioning as well as the environment in which the person lives. 
Interventions intended to promote self- management of health should 
be targeted at both the patient, the support network of caregivers and 
the supportive environments in which the patient interacts such as the 
health system, supports agencies and extended networks of family 
and friends (Marks & Sisirak,2013). Research has demonstrated that 
disease- management interventions which include self- management 
aspects produce positive impact on health outcomes for people with 
IDD. For example, a community- based health intervention devel-
oped using peers and diabetes educators was successful in increasing 
physical activity and changing eating behaviour, leading to improved 
clinical outcomes in a group of adults with mild IDD (Bazzano et al., 
2009). Another study of adults with diabetes and IDD found that most 
participants were able to participate in self- management activities, 
although with assistance from caregivers. Support from others was 
important in this process (Hale, Trip, Whitehead, & Conder, 2011). A 
small study of patients with mild intellectual disability found that the 
participants had good understanding of the importance of managing 
their asthma medication regimen (Davis, 2016).
In patients who have asthma but do not have IDD, asthma is not well 
controlled. Population- based studies finding that between 55% and 59% 
of people with asthma are controlled based on assessment of symptoms 
using standardised instruments (Chapman, Boulet, Rea, & Franssen, 
2008; Peters et al., 2007; Schatz et al., 2007). There are no studies of 
the level of control of asthma for patients with IDD and asthma.
2  | RE VIE W OF THE LITER ATURE
Caregivers have an important role in ensuring safe and effective use 
of medications by people with IDD. Caregivers encompass a wide 
range of people who provide support for daily functional activities 
for the person with IDD. Caregivers include family, friends and em-
ployed support personnel hired by the person with IDD or provided 
by a supports agency. A recent survey of caregivers of adults who 
have IDD identified their level of involvement in medication man-
agement for people with IDD, with over 70% of respondents indi-
cating that they obtained medication from pharmacies, reminded 
the person with IDD to take medication, and physically handed the 
medication to the person with IDD when it was time to take a dose 
(Erickson & LeRoy, 2015). In regard to asthma specifically, an excel-
lent qualitative study provides evidence of the needs that employed 
caregivers, or direct support professionals (DSPs) have in regard to 
assisting in the overall asthma management of their clients who have 
IDD (Davis et al., 2015). Davis et al found that DSPs are integral to 
the support of people with IDD and asthma, and that DSPs feel more 
training is needed to be able to properly fulfil their role in support-
ing the health needs of the person with IDD. Specifically, training 
on appropriate inhaler technique as well as provision of appropri-
ate decision supports tools to judge when reliever medications are 
needed are examples of important findings. The same researchers 
also provided evidence that people with IDD and asthma often do 
not perform inhaler technique appropriately (Davis et al., 2016).
Successful management of asthma requires knowledge of asthma 
triggers and treatment, correct inhaler technique, understanding an 
asthma action plan, understanding the use of a peak flow metre, accu-
rate interpretation of breathing symptoms, use of spacer devices and 
adherence to therapy. Appropriate management leads to maintained or 
improved control of asthma, which improves quality of life and reduces 
morbidity and mortality associated with the illness. Identification of 
problems associated with medication management may guide inter-
ventions to further develop self- management interventions specific to 
the needs of unique populations such as patients with IDD. Little is 
known about the overall level of control of asthma in patient with IDD, 
or of the ability of caregivers who are involved in medication manage-
ment to adequately manage the medications used to control asthma.
3  | RESE ARCH QUESTION/HYPOTHESES
The goal of this pilot study was to assess the understanding of 
asthma self- management concepts of caregivers who provide medi-
cation management assistance to people who have intellectual or 
developmental disabilities and asthma. Secondary objectives were 
to measure asthma control and medication adherence of adult pa-
tients with IDD and asthma. It is anticipated that findings from this 
study will be used to develop a larger, multicenter study that incor-
porates assessment and intervention.
4  | MATERIAL S AND METHODS
4.1 | Subjects and survey method
The subject of this study was the caregiver of an adult (age 
18 years or older) patient with IDD and asthma. A large health 
system located in a Midwestern state (United States) maintains 
an electronic data warehouse. Using the query tool DataDirect, 
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investigators are able to search for and identify patients with vari-
ous demographic and medical characteristics once a study has ap-
proval by the human investigations committee. To create a sample 
of caregivers of people with IDD, the investigators followed the 
logic of first identifying patients with IDD and asthma who were 
seen by clinicians in the adult general medicine or family medicine 
clinics within the health system, which would lead to the caregiver 
who assists in managing medication. To be included in the study, 
the caregiver must have been age 18 years or older. Caregivers 
were identified by searching the health system’s data warehouse 
for patients who have asthma, were age 18 years and older and 
who had a diagnosis related to IDD. The IDD- related conditions 
identified for this study were based on ICD9 classifications and 
included Mental Retardation (317, 318, and 319), Down syndrome, 
Foetal Alcohol Syndrome, Autism Spectrum Disorder, Other 
Genetic Abnormalities, Cerebral Palsy and Developmental Delay. 
The diagnosis associated with IDD must have been documented at 
least once in any procedure, visit or hospitalisation/emergent care 
event from 2012 to 2014. Once the IDD sample was constructed, 
it was further searched for patients with asthma. The diagnosis 
of asthma must have been documented at least two times in the 
electronic health records, from 2013 to the end of 2014. The re-
quirement of being documented at least two times was an attempt 
to increase the likelihood that the patient had a confirmed diag-
nosis of asthma. The final list of patients with IDD and asthma 
underwent a validation check by the investigators reviewing the 
electronic medical record. The query initially identified 453 pa-
tients with IDD diagnosis. When further filtered by asthma diag-
nosis and chart review to confirm both IDD and asthma diagnosis, 
239 subjects were identified for the study sample. Addresses 
were obtained from the medical record and survey packets sent 
to the address of the patient, but labelled for the caregiver. The 
covering letter in the survey packet was written to indicate that 
the study was focused on the caregiver who assists in managing 
asthma medicine. Three mailings were made, including the initial 
survey packet, a reminder postcard sent 2 weeks later, followed 
by a second survey packet 4 weeks after the initial mailing to 
subjects who had not yet responded. A total of five patients or 
caregivers contacted the investigator to opt out of the study and 
12 packets were not deliverable and returned. Of the remaining 
222 potential subjects, 18 returned survey packets, for a response 
rate of 8.1%. Therefore, due to the small sample size, this study 
is considered to be a pilot study, in which we are identifying the 
most salient and potential caregiver and patient factors that may 
be associated with asthma self- management concepts as well as 
control for patients with IDD and asthma, keeping in mind that 
caregivers are an integral part of successful medication manage-
ment. The study was approved by the Institutional Review Board.
The study survey consists of a number of questionnaires in-
cluded to measure specific concepts. The Asthma Self- Management 
Questionnaire, the health literacy scale and the inhaler technique 
questionnaire are direct measures of the caregiver’s understanding 
and health literacy. The questions about the patient’s use of spacer 
devices, peak flow metres and having an asthma action plan are asked 
of the caregiver with the notion that they have direct knowledge of 
the use or the presence of these devices or asthma action plan. The 
questionnaires assessing asthma medication adherence and asthma 
control were originally developed to be self- administered by the pa-
tient. For this study, the caregiver was instructed to consider the 
care- recipient when answering each question. As for medication 
adherence, we feel that the caregiver is knowledgeable to factors 
related to the medication- taking behaviour of the care- recipient, as 
they are often very involved in overseeing medication management. 
We did not conduct a validation of this technique prior to initiat-
ing the study. There is an opportunity for misrepresentation of the 
findings when someone other than the patient completes the ques-
tionnaire. In pre- test, we found that patients with IDD had difficulty 
completing the instrument. We elected to utilise the caregiver to 
function as the surrogate responder for the items. Literature, primar-
ily in cancer care, demonstrates that caregiver and patient assess-
ment of symptoms such as pain and fatigue are at least moderately 
correlated (Desbiens & Mueller- Rizner, 2000; McPherson, Wilson, 
Lobchuk, & Brajtman, 2008; Poort et al., 2016). We expected that 
the caregiver completing the survey would have a close enough rela-
tionship with the patient to be able to complete the questions with a 
fair representation of the answer. This study, being a pilot study, will 
provide initial evidence as to the feasibility of being able to utilise the 
caregiver as a survey surrogate. Future research may be conducted 
to further determine the validity of the process.
4.2 | Data
4.2.1 | Characteristic of the caregiver and the 
person with IDD
Characteristics of the caregiver included age, gender, race, level of 
formal education, whether they ever received training in asthma 
management or medication management, and personal history of 
medication use. To measure functional independence of the person 
with IDD, the caregiver was asked how many hours, on average, did 
the person require support per day. A separate question assessed the 
level of patient independence in self- managing asthma medication.
4.2.2 | Caregiver asthma self- 
management knowledge
It is assumed that in order for caregivers to provide care, they must 
have adequate knowledge and understanding of the illnesses and 
related treatments that the care- recipient experiences. We there-
fore used the Asthma Self- Management Questionnaire to assess 
caregiver understanding of key components of successful asthma 
self- management It consists of sixteen multiple choice questions 
that assess medication knowledge, trigger avoidance, use of peak 
flow metres and asthma disease knowledge. The instrument has 
good psychometric properties and corresponds to changes in clini-
cal asthma status over time (Mancuso, Sayles, & Allegrante, 2009).
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4.2.3 | Caregiver inhaler technique questionnaire
A standardised checklist of inhaler technique was used to assess car-
egiver knowledge of inhaler technique. The checklist was developed 
and validated as a tool to screen patients for incorrect inhaler tech-
nique (Erickson, Horton, & Kirking, 1998).
4.2.4 | Health literacy of the caregiver
A three- item brief health literacy screening scale developed by Chew, 
Bradley, & Boyko (2004) was used to assess health literacy of the car-
egivers. The original scale instructs subjects to respond on a 5- point 
Likert scale to three items: “How often do you have problems learn-
ing about your medical condition because of difficulty understanding 
written information?” (Responses range from all of the time to none 
of the time); “How confident are you filling out medical forms by your-
self?” (Responses range from extremely to not at all); and “How often 
do you have someone help you read hospital materials?” (Responses 
range from all of the time to none of the time). The version of the 
instrument which modified the original third question to “How often 
do you have someone help you read instructions, pamphlets, or other 
written materials from your doctor or pharmacy?” was used for this 
study (Morris, MacLean, Chew, & Littenberg, 2006). After reverse- 
scoring the item addressing confidence with forms, responses to the 
three items are summed; scores range between 3 and 15, with higher 
scores indicating higher health literacy.
4.2.5 | Patient medication adherence
The Medication Adherence Report Scale for Asthma (MARS- A) was 
used as a self- report measure of adherence to each of the subject’s 
controller medications (Cohen et al., 2009). The MARS- A is a ten- 
item questionnaire. Medication use is rated on a 5- point Likert scale 
with higher scores indicating better adherence. The MARS- A has 
been tested and has strong psychometric properties. The caregiver 
completed the MARS- A with the focus on the patient medication- 
taking behaviour. A MARS- A score of 4.5 or higher was defined as 
good adherence.
4.2.6 | Patient use of spacer device/The presence of 
an asthma action plan
A question was asked whether or not the patient uses a spacer de-
vice to assist in the drug delivery process for metered dose inhalers. 
The caregiver was asked whether the patient had an asthma action 
plan produced by a healthcare provider.
4.2.7 | Asthma control
The Asthma Control Questionnaire (ACQ) was used to measure 
the level of control of asthma (Juniper, O’Byrne, Guyatt, Ferrie, 
& King, 1999). The ACQ was developed as a way to determine 
the degree of asthma control using information from the patient 
about symptoms, medication utilisation and pulmonary function 
testing. The symptoms- only version of the ACQ was used for this 
study, as it does not include pulmonary function test information 
or the question on medication utilisation (Juniper, Svensson, Mörk, 
& Ståhl, 2005). It includes five items to assess the patient’s limita-
tions due to asthma in performing activities of daily living. Generally, 
asthma is considered controlled with ACQ scores below 1.5 (Juniper, 
Bousquet, Abetz, & Bateman, 2006). This value provides a positive 
predictive value of 0.84 and negative predictive value of 0.63. A 
more sensitive cut- point described as being more useful for clinical 
assessment is 0.75. This value provides a negative predictive value 
of 0.81 and positive predictive value of 0.72. These two values were 
used for this study to differentiate subjects as controlled versus not 
controlled. The caregiver completed the ACQ with the focus on the 
patient’s symptoms.
4.2.8 | Barriers to medication management and 
asthma control
A qualitative assessment of barriers was conducted using open- 
ended questions, asking the caregiver to describe barriers associ-
ated with using asthma medications safely and effectively, as well as 
to describe barriers to controlling asthma.
4.3 | Data analysis
Description of the sample was conducted using means with stand-
ard deviation for continuous variables and frequencies with per-
centage for categorical variables. Because of the small number of 
respondents, further comparative analyses between caregiver and 
patient characteristics and asthma self- management scale scores 
were not conducted. Qualitative data described by the respond-
ents about barriers to obtaining and used asthma medication were 
analysed using a thematic content analysis. This method was per-
formed to identify issues encountered by caregivers around asthma 
management and medication management was coded. The analysis 
was performed inductively where the themes emerged from the 
data. The passages coded were ordered by thematic similarity or 
relationship into a project codebook and combined to reduce data 
to conceptualised themes. Finally, through a thorough process of 
analysis and comparison back to the original transcripts, data were 
grouped into major themes. The codebooks obtained by each re-
viewer were discussed at two different times and consensus on in-
terpretation of the content was achieved. Final themes were then 
counted to determine how many times they were mentioned by 
respondents.
5  | RESULTS
A total of 19 caregivers completed the survey. Characteristics of 
the respondents are presented in Table 1. All caregivers were family 
members of the person with IDD, had a mean age of 53 years, were 
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female and had at least some college training as a measure of formal 
education. One- third had education in a health- related field. Most 
respondents were classified as having acceptable health literacy. 
The person with IDD required supervision, on average, over 18 hr 
per day. Refer to Table 2 for data on the person with IDD. Almost 
two- thirds of the people with IDD depended completely on the car-
egiver to assist them to manage their asthma medication therapy, 
with approximately another one- third requiring some assistance. 
Assessment of adherence to asthma medication, assessed by the 
MARS- A scale and using the predetermined cut- point in the score, 
found that almost 75% of the patients were classified in the lower 
adherence. Just over half of the patients had an asthma action plan, 
and only twelve per cent used a peak flow metre in their overall man-
agement of asthma.
The Asthma Control Questionnaire scores ranged from 0 to 4.2 
(lower values indicate better control), with a mean of 1.2 (±1.2). The 
number of patients considered to have asthma that was controlled 
was 12 (63.2%) using the score threshold of 1.5. If the more clini-
cally sensitive score of 0.75 was used as the cut- point, a total of 10 
(52.6%) patients were considered controlled.
Caregiver scores on the Asthma Self- Management 
Questionnaire ranged from 12.5 to 81.3, with a mean of 56.6 
(±22). The highest score achievable is 100, indicating the highest 
level of understanding of asthma management. Examining the cor-
rect responses for each question within the ASMQ, the areas of 
greatest knowledge deficit include interpretation of prescription 
TABLE  1 Characteristics of the caregiver (n = 19 respondentsa)
Characteristic
Frequency (%) or 
Mean (SD)
Age 53.8 (12.1) 
Range 28 to 70
Gender—Female 16 (88.9)
Relationship to the patient
Parent or sibling 19 (100)
Education
Did not graduate high school 1 (5.6)
High school graduate or GED 5 (27.8)
Some college or more 12 (66.7)
Education in health care
Yes 6 (33.3)
Participate in medication administration training
Yes 5 (27.8)
Health literacy
Confidence in filling medical forms by 
self—Higher Health Literacy
16 (84.2)
Need help reading hospital materials—Higher 
Health Literacy
15 (78.9)
Problems learning about medical conditions 
because of difficulty understanding written 
information—Higher Health Literacy
16 (84.2)
Caregiver Asthma Self- Management 56.6 (22.0)
Questionnaire score. Higher score = better 
self- management knowledge
Range 12.5 to 
81.3
Caregiver inhaler technique knowledge score 6.5 (1.6)
Higher score (10 maximum) = better technique Range 4 to 9
aOne respondent did not provide answers to questions assessing car-
egiver age, gender, or education.
TABLE  2 Characteristics of the patient with asthma and 
intellectual/developmental disability (n = 19)
Characteristic Frequency (%) Mean (SD)
Age 28.3 (11.5) 
Range 19 to 65
Gender—Female 7 (37)
Intellectual/developmental disability
Cerebral palsy 8 (42.1)




Down syndrome 1 (5.3)
Number of hours per 
day the patient 
requires supervision
18.5 (9.2) 
Range 2 to 24





Depends on caregiver 12 (63.2)




Higher score = better 
adherence
Range 1.5 to 5
Asthma medication adherence scale score dichotomiseda
Higher adherence 5 (27.8)
Lower adherence 13 (72.2)
Does the patient have 
an asthma action 
plan?—Yesa
10 (55.6)






Higher score = lower 
asthma control
Range 0 to 4.2
Asthma Control Questionnaire Score Dichotomised (1.5 cut- point)




Asthma control questionnaire score dichotomised (0.75 cut- point)




aNot all subjects provided answers to these questions.
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instructions, correct use of peak flow metres, inhaler technique, 
how to prevent asthma flare- ups, reasons for asthma flares and 
what to do when asthma flares occur and the role of exercise 
with asthma. Refer to Table 3 for individual items of the ASMQ. 
Caregiver scores on the inhaler technique questionnaire were 
widely distributed, with a mean score of 6.5 (±1.6) and a range 
from 4 to 9, with 10 being the highest possible score indicating the 
greatest understanding of inhaler technique.
Responses to the open- ended questions regarding barriers to 
asthma control and barriers to asthma medication utilisation were 
summarised into specific themes. Refer to Table 4 for a summary of 
the responses. Eleven respondents provided their thoughts about 
barriers to asthma control. The most common barrier to controlling 
asthma was inadequate education of the caregiver and patient about 
the illness and treatment. The next most common theme mentioned 
was knowing and avoiding asthma triggers. Concerning medical care 
of asthma, lack of consistent follow- up and coordination of care for 
asthma was the third barrier. The final theme was familiarity and 
ability of the clinician to work with patients with IDD.
Thirteen respondents provided information regarding barriers to 
asthma medication management. The most frequently cited barrier 
was struggling to know good inhaler technique. That was followed 
by education of the patient and the caregiver. Forgetfulness was the 
third most frequently cited barrier, which included forgetting to use 
the medication at the prescribed time or forgetting to take medi-
cation when away from home. The last three barriers were cited 
once each and included poor communication between caregiver and 
patient, lack of adequate follow- up by clinicians (too long of a time 
between visits) and cost of medication.
6  | DISCUSSION
It is generally acknowledged that knowledge of asthma management 
is necessary to be an effective self- manager (Allen & Jones, 1998; 
Kotses et al., 1995; Meyer, Sternfels, Fagan, Copeland, & Ford, 2001; 
van der Palen, Klein, & Seydel, 1997). Family caregiver scores on the 
Asthma Self- Management Questionnaire (ASMQ) in the present 
TABLE  3 Asthma self- management questionnaire—individual 
item results (n = 19)
Individual ASMQ Questions (… with 
correct response)
Number and percent 
correct response
A main method to prevent asthma 
flare- ups is to … get a flu vaccine
5 (26.3)
Taking the prescribed two puffs of you 
inhaler two times a day … is not the same 
as any other regimen
8 (42.1)
If you are not having asthma symptoms … 
you should still avoid triggers
14 (73.7)
Maintenance medicines … help prevent 
future symptoms
15 (78.9)
The correct way to use peak flow metre is 
to … take a deep breath then blow into 
the mouthpiece as fast as you can
2 (10.5)
Rescue medicines … should not be taken 
more than three or four times a day
16 (84.2)
When using your inhaler, you should … 
inhale slowly
9 (47.4)
After you have used your inhaler, you 
should … hold your breath for several 
seconds
12 (63.2)
If you are having symptoms and don’t know 
why, the first thing you should do is … 
change your immediate environment
5 (26.3)
Taking more rescue medications than 
prescribed … may mean you need more 
maintenance medicine
12 (63.2)
The benefit of using a peak flow metre 
every day is … you can detect small 
changes in lung function even before 
symptoms start
11 (57.9)
For people with asthma, exercise … can 
help improve breathing capacity
8 (42.1)
Asthma can be cured by … there is no 
known cure for asthma
16 (84.2)
Asthma flare- ups … can occur when several 
minor triggers come together
9 (47.4)
If you are prescribed a seven- day course of 
steroid pills … you should finish the 
prescription even if you feel better after 
several doses
16 (84.2)
Which of the following can help control 
asthma? … Reducing the stress level, 
drinking plenty of water to stay hydrated, 
and avoiding foods with sulphites, such as 
dry fruits and wine
14 (73.7)
TABLE  4 Themes present in the qualitative assessment
Barriers to controlling asthma
% of caregivers 
(n = 11)
Education of patient and/or caregiver 36.4
Asthma triggers and symptoms 27.3
Lack of follow- up/care coordination 18.2
Clinician familiarity/ability to work with 
patients with IDD
18.2
Barriers to using asthma medication safely 
and effectively
% of caregivers 
(n = 13)
Knowing and performing correct inhaler 
technique
46.2




Communication between patient and 
caregiver
7.7
Lack of follow- up/care coordination 7.7
Cost of medication 7.7
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study were not that much different from scores reported from the 
initial development and validation study of the instrument (Mancuso 
et al., 2009). The average caregivers’ ASMQ score was 56 ± 22 for 
the present study, while the mean score during the initial develop-
ment and validation stage was 60 ± 20, with a 12- month follow- up 
score of 68 ± 18. In the qualitative portion of the present study, the 
most commonly mentioned theme that was perceived to be asso-
ciated with barriers to asthma control and safe medication use by 
caregivers was knowledge- base for asthma management. This coin-
cides with the relatively poor scores on the asthma self- management 
questionnaire as well as the inhaler technique questionnaire.
An interesting finding of the current study is that family care-
givers had high scores on the health literacy assessment but did 
not do well on the Asthma Self- Management Questionnaire or 
Inhaler Technique Questionnaire. This relationship suggests that 
family caregivers are capable of understanding and learning asthma 
self- management information and skills. Although not included in 
this study, employed direct support staff, another group of care-
givers often involved in managing a care- recipient’s medications, 
have been found to have health literacy similar to that of family 
caregivers (Erickson & LeRoy, 2015). Clinicians and asthma edu-
cators, when working with a patient with IDD, should understand 
that caregivers may provide a significant amount of assistance to 
patients with IDD. The clinician and educator should determine 
to what extent the caregiver should be incorporated into asthma 
self- management training process. The concepts of asthma self- 
management that seemed to have the greatest deficits identified 
in this small pilot study include information about asthma flare- ups 
such as how to prevent flare- ups, reasons for asthma flares and 
what to do when asthma flares do occur. An area of concern was 
understanding the role of exercise with asthma. Another concern-
ing area is that of interpreting prescription instructions as well as 
use of peak flow metres. Lastly, understanding of inhaler technique 
was lacking not only in the ASMQ, but also in the separate inhaler 
technique questionnaire. Appropriate inhaler technique is crucial 
to adequate delivery of medication to the sites of action within the 
airways of the lungs and symptom control (Giraud & Roche, 2002). 
A study to assess the ability of individuals who had IDD and asthma 
to appropriately use various inhalers found that no person with 
IDD could correctly us any inhaler device (Davis et al., 2016). A sys-
tematic review of studies of patients who do not have IDD found 
that 46% to 59% of patients used inhalers incorrectly (Cochrane, 
Bala, Downs, Mauskopf, & Ben- Joseph, 2000). At the same time, 
studies have demonstrated that patients, including many who have 
IDD, are able to learn proper technique which leads to improved 
symptom control (Davis et al., 2016; Newman, Weisz, Talaee, & 
Clarke, 1991).
Davis et al. (2015) conducted a qualitative study of support per-
sonnel who provide direct care to people with IDD, documenting 
their experiences with asthma medication management. The pri-
mary findings were that support personnel perform many duties, of 
which medication management is one. Other research confirms that 
this is true with family caregivers as well (Erickson, Salgado, & Tan, 
2016). Another important finding in the study by Davis et al. was 
that there appeared to be variation in the level of medication train-
ing received by employed support personnel. The support personnel 
perceived that their role in managing their client’s medication is im-
portant. The study also found that there may be a lack of decision 
support available to assist caregivers when performing tasks asso-
ciated with medication management. These perceptions are similar 
to those reported by family caregivers in the present study. Of the 
eleven family caregivers answering the open- ended questions re-
lated to barriers to controlling asthma, 36% (n = 4) cited the need 
for education of the caregiver and patient, along with being able to 
identify and understand common triggers and asthma symptoms. As 
far as barriers to using medication safely, 46% (six of the thirteen 
family caregivers) were most concerned with knowing and perform-
ing inhaler technique correctly, followed again by education of both 
the patient and caregiver, followed by forgetting to have medication 
with them when it is time to take it. Less commonly mentioned, but 
consistent in the themes were issues with communication and co-
ordination of care between patient, clinician and caregiver. These 
issues are consistent with findings from another qualitative study of 
caregivers who assist people with IDD managing their medication 
(Erickson et al., 2016).
Additional findings from this pilot study were that over a third of 
the patients with IDD did not have desired control of asthma. This 
is one of the first studies to provide evidence of the level of asthma 
control in patients with IDD using a validated measure. A number 
of potential factors measured in this study that may have contrib-
uted to lack of control of asthma included nonadherence with con-
troller medications and a modest level of caregiver understanding 
of asthma management and inhaler technique. The findings of this 
pilot study are similar to those of patients without IDD. In the gen-
eral population, as well as in study samples from physician practices, 
asthma is not well controlled, with population- based studies finding 
that between 55% and 59% of people with asthma are controlled 
based on assessment of symptoms using standardised instruments 
(Chapman et al., 2008; Peters et al., 2007; Schatz et al., 2007). In a 
study using telephone- administered surveys of patients with asthma 
that also included data from the patients’ prescribers, it was deter-
mined that 59% were uncontrolled, 19% well controlled and 23% to-
tally controlled. These values are not too dissimilar to those reported 
in this study. Future research should focus on the patient, treatment 
and social variables that may be associated with asthma control.
For asthma to be controlled, patients need to be adherent to 
controller medication (Janson, Wong McGrath, Covington, Cheng, & 
Boushey, 2009; Murphy et al., 2012). Studies on medication adher-
ence for people with IDD are not common. The extent of adherence 
to controller medications by patients in the general population for 
asthma therapy varies widely based on the method used to assess 
adherence, treatment type and age group. Studies have documented 
adherence rates to controller therapy that range from 20% to 70% 
in the general population (Baum & Creer, 1986; DeSmet, Erickson, & 
Kirking, 2006; Gong, Simmons, Clark, & Tashkin, 1988; Zora, Lutz, & 
Tinkelman, 1989).
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6.1 | Limitations
The major limitation of this study is the small sample size. This was 
most likely due to several issues related to the method used to re-
cruit respondents. We did not include an incentive to participate, 
nor did we reach out to patients other than by mail. In that light, 
we consider this study to be a pilot study, providing us and other 
researchers with a glimpse as to what may be important when ex-
amining the association between asthma management and asthma 
control in patients with IDD. It is not possible to generalise the find-
ings of this small study to all caregivers of people with IDD who 
have asthma, but it does provide a sense of a number of factors 
that could be more fully explored in future research. Future stud-
ies should include not only a larger number of subjects, but also 
ensure that an adequate number of various types of caregivers are 
included, which would include family and friends (informal caregiv-
ers) and employed support staff, such as direct support profession-
als staffing group homes, supported apartments or townhouses, 
or direct- hire personnel assisting an individual within their own 
home. Strategies to enrol paid carers may be to work directly with 
the staffing and supports agencies which employ these individuals. 
Other opportunities to increase the sample size and response rates 
of all types of caregivers would include offering incentives to par-
ticipate or to meet potential subjects face to face in clinics or other 
health- related settings.
Another limitation of this study is that it focused on the care-
giver rather than on the patient in regard to asthma management 
and knowledge. Future work should include the patient with IDD. 
Evidence suggests that patients with IDD do not receive the 
same level of health education and health promotion opportuni-
ties as the general public (Taggart & Cousins, 2014). This may be 
due to the general misconception that people with IDD lack the 
cognitive ability to understand their complex disease state and 
therefore lack the ability to self- manage asthma. However, more 
than half of people with IDD are capable of understanding and 
responding consistently to interview questions in research stud-
ies as well as comprehend basic medical information (Strydom & 
Hall, 2001). Identification of problems in medication management 
among patients with IDD is essential to develop interventions 
that are tailored to address their needs. Future studies could be 
developed to test the influence of a targeted or tailored asthma 
self- management programme designed for people with IDD. This 
type of programme could be instituted by supports agencies that 
provide care to people with asthma and IDD. Nationwide, this 
would potentially impact over two hundred thousand people with 
asthma and IDD- related conditions.
7  | CONCLUSION
The results of this pilot study provide initial insight into the level 
of knowledge and skill of asthma medication management in car-
egivers of people with IDD. Family caregivers who responded to this 
survey were found to contribute substantially to asthma medication 
management for the person they provide care for. Despite adequate 
levels of health literacy, the family caregivers had generally poor 
understanding of overall asthma self- management concepts. These 
trends reveal gaps in knowledge of asthma management and the 
potential need for additional education and assessment of skills for 
the caregivers. Improving caregiver and patient knowledge and skills 
may lead to better asthma control. The present study suggests that 
conducting well- designed, larger studies that include the patient as 
well as family and paid carers are warranted.
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